Aurora Cannabis Inc T.ACB

Alternate Symbol(s): ACB | T.ACB.WS.U

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by Raguu17on Sep 24, 2019 11:36am

136 Views

Post# 30159041

RE:RE:Aurora to address concerns of current business models .

Have they responded yet?

Very curious as to what they say to you.

herewegotoday wrote: I agree. I posted 'New to the Message Board' a few days ago, urging everyone to do the same.
Here is the contact info:

Investor Relations:

Ananth Krishnan, VP, Capital Markets & Investor Relations

Rob Kelly, Director, Investor Relations

ir@auroramj.com

1-855-279-4652

I emailed IR and yesterday I received a very dissappointing response. Happy to post it if interested? I then emailed back with my dissappointment and what we as Investors are expecting from ACB.

Everyone needs to email them and put the pressure on to do something, say something. For example, if they do not come through on all this partnership news, it is for sure another clear example of 'over promise and under deliver' to which I will have lost faith. I mean really, they basically said we would have positve EBITDA up until last Midas Letter interview in August 5, just weeks before the actual release of the numbers. WTF.
They need to know that this is how we feel.
EVERYONE EMAIL THEM NOW AND LET THEM KNOW THIS IS NOT ACCEPTABLE.